BioSpace News Archive

Drug Development

Pfizer Announces Top-Line Results from Phase 3 Trial of LYRICA® (pregabalin) in Primary Generalized Tonic-Clonic Seizures

Pfizer Inc. announced that a Phase 3 study to assess the use of LYRICA® as adjunctive therapy for epilepsy patients 5 to 65 years of age with primary generalized tonic-clonic seizures did not meet its primary endpoint.

May 24, 2019
·
8 min read
Business

NOVA’s Paula Apsell Named Senior Executive Producer Emerita

Paula Apsell, the award-winning science journalist who guided the PBS program “NOVA” to worldwide acclaim as the most popular science program on American television and online, has been named Senior Executive Producer Emerita.

May 24, 2019
·
2 min read
BioCapital

QIAGEN launches first FDA-approved companion diagnostic for PIK3CA biomarkers to enhance precision medicine in breast cancer

Innovative therascreen® PIK3CA RGQ PCR Kit receives U.S. regulatory approval for use in guiding treatment decisions from tissue and liquid biopsy for newly approved therapy PIQRAY® (alpelisib) from Novartis

May 24, 2019
·
2 min read
BioMidwest

Statement From Murphy Logistics Solutions Regarding Resolution Of Strike With Teamsters Local 120

We are pleased that we were able to reach a positive agreement with the Teamsters Union at the bargaining table – one that we consider a win for the employees and the company.

May 24, 2019
·
1 min read
B dot Medical Developing Ultra-compact Proton Cancer Therapy System That Can Replace X-ray Cancer Therapy System

B dot Medical Inc. announced on May 24 that the company has initiated the development of an ultra-compact proton cancer therapy system that can replace the commonly used x-ray cancer therapy system.

May 24, 2019
·
2 min read
Business

Lannett Announces CFO Retirement

Lannett Company, Inc. announced that the company’s chief financial officer, Martin Galvan, 67, will retire on August 30, 2019, following the planned submission of the company’s Form 10-K for fiscal year 2019.

May 24, 2019
·
1 min read
CTONG-OrigiMed New Clinical Trial Sharing Platform Launched during the 3rd OrigiMed Summit for Cancer Discovery

With fast advances in the medical industry, on May 11, 2019, the third OrigiMed Summit for Cancer Discovery: Immunotherapy and Targeted Therapy was successfully held in Guangzhou.

May 24, 2019
·
5 min read
Deals

Alpine Immune Sciences to Present at Upcoming Investor Conferences

Alpine Immune Sciences, Inc. announced the company will participate in three upcoming investor conferences in June.

May 24, 2019
·
1 min read
Novocure to Participate in the Jefferies 2019 Global Healthcare Conference

Novocure announced that Bill Doyle, Novocure’s Executive Chairman, will participate in the Jefferies 2019 Global Healthcare Conference on June 4, 2019, in New York City.

May 24, 2019
·
3 min read
Business

FLX Bio Announces Name Change to RAPT Therapeutics

Name Reflects Our Focus on Defeating Cancer and Allergic Inflammatory Diseases

May 24, 2019
·
4 min read